 |
Prospector
Profile
07.1433
|
| |
| Xenacare Holdings, Inc. |
NAICS |
325411 |
| 3275 W. Hillsboro Boulevard, Suite 300
Deerfield Beach, FL 33442 |
Description |
Vitamin Supplements Mfg. |
| (954) 363-4507 |
Employees |
0 |
| http://www.xenacare.com/ |
Revenue |
(mil) |
0.0420 |
| |
Income |
(mil) |
-0.8450 |
| |
Assets |
(mil) |
0.7540 |
| |
Liability |
(mil) |
0.0200 |
| |
(for the year ended 2006-09-30) |
| |
|
Category:
Loss/Deficit
|
| |
|
Event:
Xenacare Holdings, Inc. had a $378,657 net loss for the three months ended June 30, 2007, lower than the $708,194 net loss incurred during the three months ended June 30, 2006. For the six months ended June 30, 2007, the Company had a $853,964 net loss, lower than the $1,126,976 net loss reported during the first half of 2006. The Company's balance sheet at June 30, 2007 showed an accumulated deficit of $4,898,013 and stockholder's deficit of $518,170.
|
| |
|
Intellectual Property:
XenaCare pursues registrations for all of the trademarks associated with its key products. The Company relies on common law trademark rights to protect unregistered trademarks as well as trade dress rights. The Company intends to register trademarks in certain foreign jurisdictions where its products are sold. The Company will continue to use the current business strategy of adding proprietary blends to each formula, which makes formula replication challenging for any possible competitor. [SEC Filing SB-2 12-22-06]
|
| |
|
Description:
The Company formulates, markets and sells nutrition supplement products (NSPs) and personal lubrication gels.
|
| |
|
Officers:
Dr. Alan Xenakis (Chair & CEO); Bobby Story (CFO & Dir.); Frank Rizzo (Pres. & Dir.)
|
| |
|
Securities:
23,067,192 common shares outstanding as of August 17, 2007.
|
| |
| |
| |
| return to main page |
|
|
